Results 281 to 290 of about 2,811,792 (409)

Associations of ambient coarse particulate matter, nitrogen dioxide, and carbon monoxide with the risk of kidney disease: A cohort study [PDF]

, 2017
Al-Aly, Ziyad, Bowe, Benjamin, Li, Tingting, Xian, Hong, Xie, Yan, Yan, Yan   +5 more
core   +2 more sources

Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease

, 2019
Yao Qiao, Jung‐Im Shin, Yingying Sang, Lesley A. Inker, Alex Secora, Shengyuan Luo, Josef Coresh, G. Caleb Alexander, John W. Jackson, Alex R. Chang, Morgan E. Grams   +10 more
openalex   +2 more sources

Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

Proceedings of the National Academy of Sciences of the United States of America, 2003
R. Santos, A. C. S. e Silva, C. Maric, Denise M. R. Silva, Raquel P. Machado, I. de Buhr, S. Heringer-walther, S. Pinheiro, M. T. Lopes, M. Bader, E. P. Mendes, V. S. Lemos, M. Campagnole-Santos, H. Schultheiss, R. Speth, T. Walther   +15 more
semanticscholar   +1 more source

Real-World Value of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) in Korea: Moving From Cost-Effectiveness to Implementation. [PDF]

Korean Circ J
Kim TH.
europepmc   +1 more source

Differential effects of angiotensin II type I receptor blockers on reducing intraocular pressure and TGFβ signaling in the mouse retina

, 2018
Ralph J. Hazlewood, Qingxia Chen, Frances K. Clark, John Kuchtey, Rachel W. Kuchtey   +4 more
openalex   +2 more sources

Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction

European Journal of Heart Failure, 2015
A. Voors, M. Gori, Licette C. Y. Liu, B. Claggett, M. Zile, B. Pieske, J. McMurray, M. Packer, V. Shi, M. Lefkowitz, S. Solomon   +10 more
semanticscholar   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma. [PDF]

Cancer Diagn Progn
Ishikawa T, Sato R, Natsui H, Iwasawa T, Ogawa M, Kobayashi Y, Sato T, Yokoyama J, Honma T.   +8 more
europepmc   +1 more source

Neuroprotective effects of angiotensin receptor blockers.

American Journal of Hypertension, 2015
S. Villapol, J. Saavedra
semanticscholar   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source